Jiachi Ma, Yuzhong Chen, Wanqing Liang, Lei Li, Jun Du, Chengwu Pan, & Chensong Zhang. (2021). ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJiachi Ma, Yuzhong Chen, Wanqing Liang, Lei Li, Jun Du, Chengwu Pan, and Chensong Zhang. ROS-responsive Dimeric Prodrug-based Nanomedicine Targeted Therapy for Gastric Cancer. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationJiachi Ma, et al. ROS-responsive Dimeric Prodrug-based Nanomedicine Targeted Therapy for Gastric Cancer. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.